-
公开(公告)号：KR1020040018233A
公开(公告)日：2004-03-02
申请号：KR1020030094612
申请日：2003-12-22
Applicant: 대한민국(농촌진흥청장)
IPC: A61K35/64
CPC classification number: A61K35/63
Abstract: PURPOSE: Provided is a pharmaceutical composition containing a cricket extract is provided which has liver-protective effect, antifatigue effect, alcohol detoxification effect, and lipid-peroxidation formation inhibition effect. CONSTITUTION: A pharmaceutical composition for liver-protection, alcohol detoxification, and lipid-peroxidation formation inhibition is characterized by containing, as an active ingredient, a cricket extract which is prepared by using C1-C4 alcohol as an extraction solvent. It is formulated into a drink.
Abstract translation: 目的：提供含有蟋蟀提取物的药物组合物，其具有肝保护作用，抗疲劳作用，醇解毒作用和脂质过氧化形成抑制作用。 构成：用于肝保护，酒精解毒和脂质 - 过氧化物形成抑制的药物组合物的特征在于，含有通过使用C1-C4醇作为提取溶剂制备的板球提取物作为活性成分。 它被制成一杯饮料。
-
公开(公告)号：KR100396986B1
公开(公告)日：2003-09-17
申请号：KR1020010011449
申请日：2001-03-06
Applicant: 대한민국(농촌진흥청장) , 사회복지법인 삼성생명공익재단
IPC: C07D211/14
Abstract: PURPOSE: Provided is a process for preparing α-glycosidase inhibitor derived from powdery silkworm, which has the same decreasing effect of blood glucose level as acarbose which is a conventional therapeutic agent for diabetes. CONSTITUTION: The process for preparing α-glycosidase inhibitor comprises the steps of: freeze-drying and powdering silkworm then adding 50% ethanol to extract it; performing cation exchange column chromatography with the extract then followed by eluting it with 0.5N of NH4OH and concentrating it; dissolving the concentrate in water then followed by performing anion exchange column chromatography. eluting with water and concentrating it; dissolving the concentrate in water then followed by cation exchange column chromatography, eluting with water and 0.5N of NH4OH to obtain 5 fractions obtain one fraction respectively; and performing anion exchange column chromatography with the second fraction among the 6 fractions to obtain pure 1-dioxynojirimycin fraction.
Abstract translation: 目的：提供一种制备来源于粉状蚕的α-糖苷酶抑制剂的方法，其具有与作为常规糖尿病治疗剂的阿卡波糖相同的血糖水平降低效果。 构成：制备α-糖苷酶抑制剂的方法包括以下步骤：将家蚕冷冻干燥并粉碎，然后加入50％乙醇以提取它; 用提取物进行阳离子交换柱层析，然后用0.5N NH 4 OH洗脱并浓缩; 将浓缩物溶于水中，然后进行阴离子交换柱层析。 用水洗脱并浓缩; 将浓缩物溶于水中，然后进行阳离子交换柱层析，用水和0.5N NH 4 OH洗脱以获得5个馏分，分别得到一个馏分; 用6个级分中的第二级分进行阴离子交换柱层析，得到纯的1-二氧代野my霉素级分。
-
13.发明公开강정효과를 갖는 나방이 이전의 누에 수 번데기 추출물, 이의 제조방법 및 이를 함유하는 식품 및 약제학적 조성물 有权从雄蕊衍生的提取物及其成分，其制备方法和食品以及含有它们的药物组合物
公开(公告)号：KR1020020025637A
公开(公告)日：2002-04-04
申请号：KR1020010013729
申请日：2001-03-16
Applicant: 대한민국(농촌진흥청장) , 최진호
Abstract: PURPOSE: Provided is an extract derived from male pupae and adults of silkworm. Also, its preparation method and foods and pharmaceutical compositions containing it. The extract contains active ingredient for treating impotency, and is thus used as a material for manufacturing medicines. CONSTITUTION: The method for manufacturing the extract of male pupae and adults of silkworm is characterized by selecting male pupae and adults of silkworm using a silkworm kind of which gender can be distinguishable by colors, patterns or the like. The pharmaceutical composition characteristically contains an effective amount of the extract.
Abstract translation: 目的：提供来源于雄蛹和蚕成虫的提取物。 此外，其制备方法和含有它的食品和药物组合物。 提取物含有用于治疗阳ency的活性成分，因此用作制造药物的材料。 构成：制作蚕蛹和成蚕提取物的方法的特征在于使用蚕种选择蛹虫蛹和成虫，性别可以通过颜色，图案等进行区分。 药物组合物特征性地含有有效量的提取物。
-
公开(公告)号：KR101780941B1
公开(公告)日：2017-09-25
申请号：KR1020150155366
申请日：2015-11-05
Applicant: 대한민국(농촌진흥청장)
Abstract: 본발명은설원을명칭으로하는아위느타리버섯(var.) 신균주및 이의자실체재배방법에관한것으로, 보다상세하게는식용버섯으로유용한느타리속아위느타리버섯(var.)에속하는설원을명칭으로하는아위느타리버섯신균주(비산1호-20 x 백령20-199의교배주) 및이의자실체재배방법에관한것이다.
-
公开(公告)号：KR1020040029899A
公开(公告)日：2004-04-08
申请号：KR1020020060347
申请日：2002-10-02
Applicant: 대한민국(농촌진흥청장)
IPC: A61K35/64
CPC classification number: A61K35/63
Abstract: PURPOSE: Provided is a composition containing a bee larva or its extract, which has anticancer effect and thrombolytic effect, and is used in preventing and treating various kinds of cancers, and thrombus-related diseases, such as coronary thrombosis and cerebrovascular diseases. CONSTITUTION: A composition contains a bee larva, or an extract thereof. The extract comprises a water soluble, alcoholic or organic solvent extract. The composition is used in preventing and treating breast cancer, bladder cancer, skin cancer, stomach cancer, liver cancer, leukemia, and lymphoma.
Abstract translation: 目的：提供含有蜜蜂幼虫或其提取物的组合物，其具有抗癌作用和溶栓作用，用于预防和治疗各种癌症，血栓相关疾病如冠状动脉血栓形成和脑血管疾病。 构成：组合物含有蜜蜂幼虫或其提取物。 提取物包含水溶性，醇或有机溶剂提取物。 该组合物用于预防和治疗乳腺癌，膀胱癌，皮肤癌，胃癌，肝癌，白血病和淋巴瘤。
-
Patent Agency Ranking
公开(公告)号：KR100646612B1
公开(公告)日：2006-11-17
申请号：KR1020040008489
申请日：2004-02-09
Applicant: 대한민국(농촌진흥청장)
IPC: C07K14/435
Abstract: 본 발명은 인체 및 식물체의 진균성 질환의 예방 및 치료제로 유용하게 사용될 수 있는 나비목에 속하는 꿀벌부채명나방(
Galleria mellonella )의 유충으로부터 분리된 새로운 항진균 단백질의 아미노산 및 이를 암호화하는 뉴클레오티드에 관한 것이다. 본 발명에 의한 상기 항진균 단백질은 인체 및 식물체의 진균성 질환의 예방 및 치료제로 유용하게 사용될 수 있다.
곤충, 꿀벌부채명나방, 항진균 단백질, galiomicin, Galleria mellonella, 곤충생체방어물질-
17.发明授权귀뚜라미 추출물을 함유하는 간보호 효과, 강장효과,알코올해독, 과산화지질 생성 억제용 약학적 조성물 有权衍生自蟋蟀的药物组合物，发挥肝保护，抗疲劳，增强乙醇降解的活性，抑制脂质过氧化的形成
公开(公告)号：KR100498809B1
公开(公告)日：2005-07-01
申请号：KR1020030094612
申请日：2003-12-22
Applicant: 대한민국(농촌진흥청장)
IPC: A61K35/64
Abstract: 본 발명은 귀뚜라미 추출물 함유 간보호 효과, 강장피로회복, 알콜해독, 과산화지질 생성억제 용도 의약품 조성물에 관한 것으로서,
본발명에 따른 귀뚜라미 추출물은 급성간염 유발시 GOT, GPT, LDH 등 간 혈청 효소를 기존의 실리마린 대비 116%이상 회복하고, 과산화지질의 생성를 정상군 대비 140% 억제 효과를 포함한다. 또한 알콜 섭취 시 귀뚜라미 엑기스를 1시간 전에 복용하였을 때 혈청 중의 에탄올 함량이 114% 이하 감소 및 귀뚜라미 수용성 추출 분획에서는 혈청 내 알콜탈수소효소의 높은 증가(216% 이상)와 알코올 추출 분획에 있어서 미토콘드리아 내 아세트 알데하이드 탈수소효소의 높은 증가(491%)을 특징으로 한다.-
公开(公告)号：KR1020140103667A
公开(公告)日：2014-08-27
申请号：KR1020130017345
申请日：2013-02-19
Applicant: 전남대학교산학협력단
IPC: G02B5/18
CPC classification number: G02B5/1828 , G02B5/1809 , G02B6/02057 , G02B26/0808
Abstract: The present invention relates to a grid, and more specifically, to a variable grid which draws in a fluid and particles into the internal space of a grid body with the internal space and generates an ultrasonic wave to position the particles according to the period of the ultrasonic wave to form the grid based on the particles arranged in a periodical manner. The present invention includes a substrate with the internal space; a fluid inserted into the internal space; and at least one particle ring which arranges the particles in the fluid in the horizontal direction of the substrate based on the period of the ultrasonic wave.
Abstract translation: 本发明涉及一种格栅，更具体地说，涉及一种可变格栅，其将流体和颗粒吸入具有内部空间的格栅体的内部空间中，并产生超声波以根据颗粒的周期定位颗粒 超声波基于按周期排列的颗粒形成网格。 本发明包括具有内部空间的基板; 插入内部空间的流体; 以及至少一个颗粒环，其基于所述超声波的周期，在所述基板的水平方向上将所述粒子排列在所述流体中。
-
公开(公告)号：KR100882861B1
公开(公告)日：2009-02-10
申请号：KR1020070055625
申请日：2007-06-07
Applicant: 전남대학교산학협력단
Abstract: 본 발명은 장거리 가변형 광 지연장치에 관한 것이다.
본 발명의 광 지연장치는 기본적으로, 중앙에 공동코어를 형성한 광섬유와, 광섬유의 일단에 접속되며 유동액체를 공동코어로 내부로 유입시키는 펌핑부를 구성하며, 공동코어 내부에 삽입되어 유동액체에 의해 공동코어 내부를 이동하는 반사체를 포함한다.
본 발명의 주요 특장점에 의하면, 종래 수~수십㎜에 머물렀던 광 지연길이가 수~수십m 이상으로 확장된다.
광 지연장치, 공동코어, 반사체, 유동액체-
公开(公告)号：KR1020080107635A
公开(公告)日：2008-12-11
申请号：KR1020070055625
申请日：2007-06-07
Applicant: 전남대학교산학협력단
Abstract: A long-distance variable optical delay apparatus is provided to expand the length of optical delay to several meters and realize connection with the conventional device, while minimizing light loss. A long-distance variable optical delay apparatus(100) includes an optical fiber forming a cavity core at the center and a pumping area(120) inflows the fluid of the high reflective to the inside of a cavity core while being connected with one end of the optical fiber. A fluid is the Hydrargyrum(Hg), and the optical fiber is a collaboration optical fiber or a photonic crystal optical fiber or photonic band gap optical fiber, the reflector is inserted into inside of cavity core and is moved inside of the cavity core by the fluid.
Abstract translation: 提供了一种长距离可变光延迟装置，以将光延迟的长度扩展到几米，并实现与传统装置的连接，同时最小化光损失。 长距离可变光延迟装置（100）包括在中心形成腔芯的光纤，并且泵送区域（120）将高反射的流体流入空腔芯的内部，同时与 光纤。 流体是Hydrargyrum（Hg），光纤是协作光纤或光子晶体光纤或光子带隙光纤，反射器插入腔芯内部，并通过腔体芯内移动 流体。
-
-
-
-
-
-
-
-
-
Search Results
23
records
(took 0.021 seconds)
